Neuroprotective role of hydralazine in rat spinal cord injury-attenuation of acrolein-mediated damage

Journal of Neurochemistry

Volumn 129, Issue 2, 2014, Pages 339-349

  Park, Jonghyuck ^a,b   Zheng, Lingxing ^a,b   Marquis, Andrew ^a   Walls, Michael ^a   Duerstock, Brad ^a,b   Pond, Amber ^a   Vega Alvarez, Sasha ^a   Wang, He ^b   Ouyang, Zheng ^b   Shi, Riyi ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

acrolein scavenger; aldehyde; lipid peroxidation; oxidative stress

Indexed keywords

ACROLEIN; HYDRALAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; HEALTH STATUS; IN VITRO STUDY; IN VIVO STUDY; INJURY SEVERITY; MALE; MOTOR DYSFUNCTION; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; TISSUE INJURY;

ACROLEIN SCAVENGER; ALDEHYDE; LIPID PEROXIDATION; OXIDATIVE STRESS;

ACROLEIN; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CONTUSIONS; HYDRALAZINE; LOCOMOTION; MALE; NEURALGIA; NEUROPROTECTIVE AGENTS; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES;

EID: 84897985731     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12628     Document Type: Article

References (68)

1. Anderson D. K., Dugan L. L., Means E. D., and, Horrocks L. A., (1994) Methylprednisolone and membrane properties of primary cultures of mouse spinal cord. Brain Res. 637, 119-125.
2. Barger S. W., Goodwin M. E., Porter M. M., and, Beggs M. L., (2007) Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J. Neurochem. 101, 1205-1213.
3. Bartholdi D., and, Schwab M. E., (1995) Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat. Brain Res. 672, 177-186.
4. Basso D. M., Beattie M. S., and, Bresnahan J. C., (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244-256.
5. Behrmann D. L., Bresnahan J. C., and, Beattie M. S., (1994) Modeling of acute spinal cord injury in the rat: Neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673. Exp. Neurol. 126, 61-75.
6. Burcham P. C., Kerr P. G., and, Fontaine F., (2000) The antihypertensive hydralazine is an efficient scavenger of acrolein. Redox Rep. 5, 47-49.
7. Burcham P. C., Fontaine F. R., Kaminskas L. M., Petersen D. R., and, Pyke S. M., (2004) Protein adduct-trapping by hydrazinophthalazine drugs: mechanisms of cytoprotection against acrolein-mediated toxicity. Mol. Pharmacol. 65, 655-664.
8. Chaplan S. R., Bach F. W., Pogrel J. W., Chung J. M., and, Yaksh T. L., (1994) Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53, 55-63.
9. Chen A., Xu X. M., Kleitman N., and, Bunge M. B., (1996) Methylprednisolone administration improves axonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord. Exp. Neurol. 138, 261-276.
10. Cole R. A., and, Weiner M. F., (1960) Clinical and theoretical observations on phenelzine (nardil), an antidepressant agent. Am. J. Psychiatry 117, 361-362.
11. Demediuk P., Saunders R. D., Anderson D. K., Means E. D., and, Horrocks L. A., (1985) Membrane lipid changes in laminectomized and traumatized cat spinal cord. Proc. Natl Acad. Sci. USA 82, 7071-7075.
12. Demediuk P., Daly M. P., and, Faden A. I., (1989) Changes in free fatty acids, phospholipids, and cholesterol following impact injury to the rat spinal cord. J. Neurosci. Res. 23, 95-106.
13. Donnelly D. J., and, Popovich P. G., (2008) Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 209, 378-388.
14. Esterbauer H., Schaur R. J., and, Zollner H., (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 11, 81-128.
15. Facchinetti F., Amadei F., Geppetti P., Tarantini F., Di Serio C., Dragotto A., Gigli P. M., Catinella S., Civelli M., and, Patacchini R., (2007) Alpha, beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am. J. Respir. Cell Mol. Biol. 37, 617-623.
16. Feng Z., Hu W., Hu Y., and, Tang M. S., (2006) Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc. Natl Acad. Sci. USA 103, 15404-15409.
17. Fitch M. T., Doller C., Combs C. K., Landreth G. E., and, Silver J., (1999) Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 19, 8182-8198.
18. George E. R., Scholten D. J., Buechler C. M., Jordan-Tibbs J., Mattice C., and, Albrecht R. M,. (1995) Failure of methylprednisolone to improve the outcome of spinal cord injuries. Am. Surg. 61, 659-663; discussion 663-654.
19. Ghilarducci D. P., and, Tjeerdema R. S., (1995) Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 144, 95-146.
20. Hall E. D., (1989) Free radicals and CNS injury. Crit. Care Clin. 5, 793-805.
21. Hamann K., and, Shi R., (2009) Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury. J. Neurochem. 111, 1348-1356.
22. Hamann K., Nehrt G., Ouyang H., Duerstock B., and, Shi R., (2008a) Hydralazine inhibits compression and acrolein-mediated injuries in ex vivo spinal cord. J. Neurochem. 104, 708-718.
23. Hamann K., Durkes A., Ouyang H., Uchida K., Pond A., and, Shi R., (2008b) Critical role of acrolein in secondary injury following ex vivo spinal cord trauma. J. Neurochem. 107, 712-721.
24. Hesterberg T. W., Lapin C. A., and, Bunn W. B., (2008) A comparison of emissions from vehicles fueled with diesel or compressed natural gas. Environ. Sci. Technol. 42, 6437-6445.
25. Hulsebosch C. E., (2008) Gliopathy ensures persistent inflammation and chronic pain after spinal cord injury. Exp. Neurol. 214, 6-9.
26. Hulsebosch C. E., Hains B. C., Crown E. D., and, Carlton S. M., (2009) Mechanisms of chronic central neuropathic pain after spinal cord injury. Brain Res. Rev. 60, 202-213.
27. Jones T. B., McDaniel E. E., and, Popovich P. G., (2005) Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr. Pharm. Des. 11, 1223-1236.
28. Kaminskas L. M., Pyke S. M., and, Burcham P. C., (2004) Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice. J. Pharmacol. Exp. Ther. 310, 1003-1010.
29. Kehrer J. P., and, Biswal S. S., (2000) The molecular effects of acrolein. Toxicol. Sci. 57, 6-15.
30. Khan M. A., (1953) Effect of hydralazine in hypertension. Br. Med. J. 1, 27-29.
31. Leung G., Sun W., Zheng L., Brookes S., Tully M., and, Shi R., (2011) Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune enchephalomyelitis mouse. Neuroscience 173, 150-155.
32. Liu-Snyder P., Borgens R. B., and, Shi R., (2006a) Hydralazine rescues PC12 cells from acrolein-mediated death. J. Neurosci. Res. 84, 219-227.
33. Liu-Snyder P., McNally H., Shi R., and, Borgens R. B., (2006b) Acrolein-mediated mechanisms of neuronal death. J. Neurosci. Res. 84, 209-218.
34. Lovell M. A., Xie C., and, Markesbery W. R., (2000) Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic. Biol. Med. 29, 714-720.
35. Lovell M. A., Xie C., and, Markesbery W. R., (2001) Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 22, 187-194.
36. Luo J., and, Shi R., (2004) Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue. Neurochem. Int. 44, 475-486.
37. Luo J., and, Shi R., (2005) Acrolein induces oxidative stress in brain mitochondria. Neurochem. Int. 46, 243-252.
38. Luo J., Robinson J. P., and, Shi R., (2005a) Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. Neurochem. Int. 47, 449-457.
39. Luo J., Uchida K., and, Shi R., (2005b) Accumulation of acrolein-protein adducts after traumatic spinal cord injury. Neurochem. Res. 30, 291-295.
40. Montine T. J., Neely M. D., Quinn J. F., Beal M. F., Markesbery W. R., Roberts L. J., and, Morrow J. D., (2002) Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic. Biol. Med. 33, 620-626.
41. Moretto N., Facchinetti F., Southworth T., Civelli M., Singh D., and, Patacchini R., (2009) alpha, beta-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L839-L848.
42. Mudge K., Van Dolson L., and, Lake A. S,. (1984) Progressive cystic degeneration of the spinal cord following spinal cord injury. Spine (Phila Pa 1976) 9, 253-255.
43. Murphy E. J., Behrmann D., Bates C. M., and, Horrocks L. A., (1994) Lipid alterations following impact spinal cord injury in the rat. Mol. Chem. Neuropathol. 23, 13-26.
44. Newcomer J. W., Farber N. B., Jevtovic-Todorovic V., Selke G., Melson A. K., Hershey T., Craft S., and, Olney J. W., (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20, 106-118.
45. Nurick S., Russell J. A., and, Deck M. D., (1970) Cystic degeneration of the spinal cord following spinal cord injury. Brain 93, 211-222.
46. Park Y. S., and, Taniguchi N., (2008) Acrolein induces inflammatory response underlying endothelial dysfunction: a risk factor for atherosclerosis. Ann. N. Y. Acad. Sci. 1126, 185-189.
47. Peasley M. A., and, Shi R., (2003) Ischemic insult exacerbates acrolein-induced conduction loss and axonal membrane disruption in guinea pig spinal cord white matter. J. Neurol. Sci. 216, 23-32.
48. Pereira J. E., Costa L. M., Cabrita A. M., et al,. (2009) Methylprednisolone fails to improve functional and histological outcome following spinal cord injury in rats. Exp. Neurol. 220, 71-81.
49. Picklo M. J., and, Montine T. J., (2001) Acrolein inhibits respiration in isolated brain mitochondria. Biochim. Biophys. Acta 1535, 145-152.
50. Reece P. A., (1981) Hydralazine and related compounds: chemistry, metabolism, and mode of action. Med. Res. Rev. 1, 73-96.
51. Reier P. J., Stensaas L. J., and, Guth L., (1983) The astrocytic scar as an impediment to regeneration in the central nervous system, in Spinal Cord Reconstruction, (, Kao C. C., Bunge R. P., and, Reier P. J., eds.), pp. 163-195. Raven Press, New York.
52. Rooney G. E., Endo T., Ameenuddin S., et al,. (2009) Importance of the vasculature in cyst formation after spinal cord injury. J. Neurosurg. Spine 11, 432-437.
53. Saunders R. D., Dugan L. L., Demediuk P., Means E. D., Horrocks L. A., and, Anderson D. K., (1987) Effects of methylprednisolone and the combination of alpha tocopherol and selinium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J. Neurochem. 49, 24-31.
54. Schnell L., Fearn S., Schwab M. E., Perry V. H., and, Anthony D. C., (1999) Cytokine-induced acute inflammation in the brain and spinal cord. J. Neuropathol. Exp. Neurol. 58, 245-254.
55. Schurch B., Wichmann W., and, Rossier A. B., (1996) Post-traumatic syringomyelia (cystic myelopathy): a prospective study of 449 patients with spinal cord injury. J. Neurol. Neurosurg. Psychiatry 60, 61-67.
56. Shi R., and, Luo L., (2006) The role of acrolein in spinal cord injury. Appl. Neurol. 2, 22-27.
57. Shi R., Luo J., and, Peasley M. A., (2002) Acrolein inflicts axonal membrane disruption and conduction loss in isolated guinea pig spinal cord. Neuroscience 115, 337-340.
58. Shi R., Rickett T., and, Sun W., (2011a) Acrolein-mediated injury in nervous system trauma and diseases. Mol. Nutr. Food Res. 55, 1320-1331.
59. Shi Y., Sun W., McBride J. J., Cheng J. X., and, Shi R., (2011b) Acrolein induces myelin damage in mammalian spinal cord. J. Neurochem. 117, 554-564.
60. Shibuta S., Varathan S., and, Mashimo T., (2006) Ketamine and thiopental sodium: individual and combined neuroprotective effects on cortical cultures exposed to NMDA or nitric oxide. Br. J. Anaesth. 97, 517-524.
61. Smith K. J., Kapoor R., and, Felts P. A., (1999) Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 9, 69-92.
62. Stevens J. F., and, Maier C. S., (2008) Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 52, 7-25.
63. Trivedi A., Olivas A. D., and, Noble-Haeusslein L. J., (2006) Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes. Clin. Neurosci. Res. 6, 283-292.
64. Wang H., Manicke N. E., Yang Q., Zheng L., Shi R., Cooks R. G., and, Ouyang Z., (2011) Direct analysis of biological tissue by paper spray mass spectrometry. Anal. Chem. 83, 1197-1201.
65. White F. A., Bhangoo S. K., and, Miller R. J., (2005) Chemokines: integrators of pain and inflammation. Nat. Rev. Drug Discovery 4, 834-844.
66. White F. A., Jung H., and, Miller R. J., (2007) Chemokines and the pathophysiology of neuropathic pain. Proc. Natl Acad. Sci. USA 104, 20151-20158.
67. Wood P. L., Khan M. A., Moskal J. R., Todd K. G., Tanay V. A., and, Baker G., (2006) Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine. Brain Res. 1122, 184-190.
68. Zheng L., Park J., Walls M., Tully M., Jannasch A., Cooper B., and, Shi R., (2013) Determination of urine 3-HPMA, a stable acrolein metabolite in a rat model of spinal cord injury. J. Neurotrauma 30, 1334-1341.